CoChat

Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis

Wirth, Eva K., Puengel, Tobias, Spranger, Joachim, Tacke, Frank · 2022 · Expert Review of Endocrinology & Metabolism

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and closely interconnected to the metabolic syndrome. Liver-specific and systemic signaling pathways orchestrating glucose and fatty acid metabolism contribute to intrahepatic accumulation of lipids and inflammatory processes eventually causing disease progression to nonalcoholic steatohepatitis (NASH), liver fibrosis, and cirrhosis. Since a high number of key regulatory genes regarding liver homeostasis are directly mediated via thyroid hormone (TH) signaling, targeting TH receptors (TRs) represent a promising therapeutic potential for the treatment of NAFLD. AREAS COVERED: In this review, we elucidate the effects of TH on metabolic regulations in the liver via local availability and actions. We discuss recent advances and the potential impact of thyromimetics in basic research and clinical trials including liver-targeted and TRβ-specific agents for the treatment of NAFLD. EXPERT OPINION: Unselective TR targeting can be accompanied by negative side effects due to high TRβ expression in other organs and TRα-mediated effects. Recent advances in drug development and the introduction of liver-targeted thyromimetics selectively activating TRβ such as Resmetirom (MGL-3196) and VK2809 bring new hope of translating the knowledge on local TH effects into effective hepatic lipid-clearing therapies against NASH.

Overview

Integrity signals

Registry

Crossref · 10.1080/17446651.2022.2110864

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 107 references

Research works printed but not linked: 10

  1. Hönes GS, 2020, Exp Clin Endocrinol Diabetes, 128, 383
  2. Magnus-Levy A, 1895, Berlin Klin Wochenschr, 32, 650
  3. Magnus-Levy A, 1896, Verhandl. D XIV Kongr. F Inn. Med. S, 140
  4. Pazos F, 1995, J Clin Endocrinol Metab, 80, 562
  5. Tzouvelekis A, 2016, Eur Respir J, 48, A780
  6. Papatheodorou I, 2020, Nucleic Acids Res, 48, D77
  7. Renko K, 2019, Thyroid, 29, A-177-A
  8. Göhmann PJ, 2019, 42nd Annual Meeting of the European Thyroid Association
  9. 10.1089/thy.2019.29087 · doi:10.1089/thy.2019.29087
  10. 10.1016/j.cgh.2021.07.039 · DOI

Cited by

See all 46

Metadata

Authors
Wirth, E. K., Puengel, T., Spranger, J., & Tacke, F.
Affiliations
  • Humboldt-Universität zu Berlin (DE)
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
  • Charité – Universitätsmedizin Berlin (DE)
Corresponding author
Tacke, Frank
Venue
Expert Review of Endocrinology & Metabolism
Published
2022-08-11
Volume
17
Issue
5
Pages
425-434
ISSN
  • 1744-6651 (ISSN-L)
  • 1744-8417
OpenAlex
W4290182828
Cited by
42
References
107
Citations by year
2026: 8 · 2025: 5 · 2024: 20 · 2023: 8 · 2022: 1
FWCI
1.35
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Review of Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • German Research Foundation (DFG SFB/TRR 296 and CRC 1382, Project-ID 403224013)
  • Berlin Institute of Health (BIH) Clinician Scientist Program
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
thyroid hormones, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, thyroid hormone receptor, resmetirom, thyromimetics, hepatic lipid accumulation, liver fibrosis, metabolic syndrome
MeSH terms
Humans, Thyroid Hormones, Disease Progression, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis. https://app.cochat.ai/papers/10.1080/17446651.2022.2110864
The paper
Wirth, E. K., Puengel, T., Spranger, J., & Tacke, F. (2022). Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis. Expert Review of Endocrinology & Metabolism. https://doi.org/10.1080/17446651.2022.2110864

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.